IkizlerTAKramerHJBeddhuS, et al.ASN Kidney Health Guidance Workgroup on Obesity and Kidney Diseases. ASN Kidney health guidance on the management of obesity in persons living with kidney diseases. J Am Soc Nephrol2024 Nov 1; 35: 1574–1588.
3.
NdumeleCERangaswamiJChowSL, et al.American Heart Association. Cardiovascular-Kidney-Metabolic health: a presidential advisory from the American Heart Association. Circulation2023 Nov 14; 148: 1606–1635.
4.
KambhamNMarkowitzGSValeriAM, et al.Obesity-related glomerulopathy: an emerging epidemic. Kidney Int2001 Apr; 59: 1498–1509. PMID: 11260414
5.
KramerHJSaranathanALukeA, et al.Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol2006 May; 17: 1453–1459. Epub 2006 Apr 5. PMID: 16597682
6.
SegevDLSimpkinsCEThompsonRE, et al.Obesity impacts access to kidney transplantation. J Am Soc Nephrol2008 Feb; 19: 349–355. Epub 2007 Dec 19. PMID: 18094366; PMCID: PMC2396750
7.
ErogluEHeimbürgerOLindholmB. Peritoneal dialysis patient selection from a comorbidity perspective. Semin Dial2022 Jan; 35: 25–39. Epub 2020 Oct 22. PMID: 33094512
8.
GhioMAlbuckAHuangP, et al.Peritoneal dialysis in the challenging abdomen: a retrospective review examining the role of obesity and adhesions. Perit Dial Int2025 Apr 16: 8968608251331839. doi: 10.1177/08968608251331839. Epub ahead of print. PMID: 40239099
9.
BrownEABlakePGBoudvilleN, et al.International society for peritoneal dialysis practice recommendations: prescribing high-quality goal-directed peritoneal dialysis. Perit Dial Int2020 May; 40: 244–253. Epub 2020 Jan 21. PMID: 32063219
10.
ShahNBennettPNChoY, et al.Exploring preconceptions as barriers to peritoneal dialysis eligibility: a global scenario-based survey of kidney care physicians. Kidney Int Rep2024 Feb 2; 9: 941–950. PMID: 38765569; PMCID: PMC11101779
11.
NyaberaAAyahOADandeG, et al.Peritoneal dialysis in patients with severe obesity: a successful single center experience. Perit Dial Int2025 Jan 22: 8968608241312841. doi: 10.1177/08968608241312841. Epub ahead of print. PMID: 39840475
12.
LiPKChowKMChoY, et al.ISPD Peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int2022 Mar; 42: 110–153.
13.
ObiYStrejaEMehrotraR, et al.Impact of obesity on modality longevity, residual kidney function, peritonitis, and survival among incident peritoneal dialysis patients. Am J Kidney Dis2018 Jun; 71: 802–813. Epub 2017 Dec 7. PMID: 29223620; PMCID: PMC5970950
14.
NessimSJKomendaPRigattoC, et al.Frequency and microbiology of peritonitis and exit-site infection among obese peritoneal dialysis patients. Perit Dial Int2013 Mar-Apr; 33: 167–174. Epub 2012 Sep 1. PMID: 22942268; PMCID: PMC3598106
15.
VanekLKurnikowskiAKrennS, et al.Semaglutide in patients with kidney failure and obesity undergoing dialysis and wishing to be transplanted: a prospective, observational, open-label study. Diabetes Obes Metab2024 Dec; 26: 5931–5941. Epub 2024 Oct 7. PMID: 39375862
16.
YavorskiyPBorrelliSEspositoK, et al.Lesson for the clinical nephrologist: glucagon-like peptide-1 receptor agonists (GLP-1 RA) in a patient with obesity and diabetic kidney disease on peritoneal dialysis. J Nephrol2025 Mar 14: 1123–1125. doi: 10.1007/s40620-025-02247-z. Epub ahead of print. PMID: 40082391
17.
PerkovicVTuttleKRRossingP, et al.FLOW Trial Committees and Investigators. Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. N Engl J Med2024 Jul 11; 391: 109–121. Epub 2024 May 24. PMID: 38785209
18.
LambieMZhaoJMcCulloughK, et al.PDOPPS Steering Committee. Variation in peritoneal dialysis time on therapy by country: results from the peritoneal dialysis outcomes and practice patterns study. Clin J Am Soc Nephrol2022 Jun; 17: 861–871. PMID: 35641246; PMCID: PMC9269666
19.
Kalantar-ZadehKRheeCMChouJ, et al.The obesity paradox in kidney disease: how to reconcile it with obesity management. Kidney Int Rep2017 Mar; 2: 271–281. Epub 2017 Feb 1. PMID: 28439569; PMCID: PMC5399774
